A New Model for Providing Cell-Free DNA and Risk Assessment for Chromosome Abnormalities in a Public Hospital Setting
Objective. Cell-free DNA (cfDNA) offers highly accurate noninvasive screening for Down syndrome. Incorporating it into routine care is complicated. We present our experience implementing a novel program for cfDNA screening, emphasizing patient education, genetic counseling, and resource management....
Saved in:
Main Authors: | Robert Wallerstein, Andrea Jelks, Matthew J. Garabedian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Pregnancy |
Online Access: | http://dx.doi.org/10.1155/2014/962720 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prenatal Diagnosis of Cystic Hygroma related to a Deletion of 16q24.1 with Haploinsufficiency of FOXF1 and FOXC2 Genes
by: Matthew J. Garabedian, et al.
Published: (2012-01-01) -
VISUALIZATION OF CHROMOSOME-SPECIFIC DNA SEQUENCES BY FLUORESCENCE IN SITU HYBRIDIZATION OF MICRODISSECTION DNA PROBES WITH METAPHASE CHROMOSOMES
by: A. G. Bogomolov, et al.
Published: (2014-12-01) -
Chromosomal Abnormalities in Syndromic Orofacial Clefts: Report of Three Children
by: Rathika Damodara Shenoy, et al.
Published: (2018-01-01) -
Down-Turner Syndrome: A Case with Double Monoclonal Chromosomal Abnormality
by: Gioconda Manassero-Morales, et al.
Published: (2016-01-01) -
Relevance of Invasive Testing in Era of Non-Invasive Testing for Prenatal Chromosomal Abnormalities
by: Abhijeet Kumar, et al.
Published: (2022-03-01)